Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 365 | 419 | 567 | 666 | 844 |
| Gross Profit | 365 | 419 | 567 | 666 | 844 |
| Operating Expenses | 78,176 | 63,140 | 68,290 | 61,656 | 194,424 |
| Operating Income | -77,811 | -62,721 | -67,723 | -60,990 | -193,580 |
| Other Income | 1,023 | 675 | 267 | 157 | 181 |
| Pre-tax Income | -76,788 | -62,046 | -67,456 | -60,833 | -193,399 |
| Net Income Continuous | -76,788 | -62,046 | -67,456 | -60,833 | -193,399 |
| Net Income | $-76,788 | $-62,046 | $-67,456 | $-60,833 | $-193,399 |
| EPS Basic Total Ops | -0.71 | -0.57 | -0.59 | -0.66 | -2.10 |
| EPS Basic Continuous Ops | -0.71 | -0.57 | -0.60 | -0.66 | -2.10 |
| EPS Diluted Total Ops | -0.71 | -0.57 | -0.59 | -0.66 | -2.10 |
| EPS Diluted Continuous Ops | -0.71 | -0.57 | -0.60 | -0.66 | -2.10 |
| EBITDA(a) | $-76,309 | $-61,065 | $-66,008 | $-59,308 | $-192,072 |